The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -5,352,890 | -3,646,165 |
| Depreciation and amortization expense | 1,045,919 | - |
| Amortization of right-of-use assets | 2,183 | 4,110 |
| Bad debt expense | 0 | 0 |
| Change in fair value of derivative liability | -311,778 | - |
| Gain on net change in fair value of equity investments | - | 5,781 |
| Gain/(loss) on crypto assets | 57 | - |
| Non-cash financing expense | - | 163,103 |
| Lease expense | 197,679 | - |
| Interest on finance leases | 119 | 332 |
| Stock-based compensation | 570,601 | 1,159,632 |
| Deferred income taxes | 18 | 22,467 |
| Depreciation and amortization expense | - | 670,191 |
| Non-cash financing expense | 364,550 | - |
| Change in fair value of convertible notes | -2,178,039 | -139,592 |
| Gain on net change in fair value of equity investments | 8,779 | - |
| Accounts receivable | 2,530,857 | 123,992 |
| Accounts receivable - related party | 155,716 | 44,459 |
| Lease expense | - | 90,469 |
| Inventory | 570,174 | 157,650 |
| Prepaid expenses and other assets | -36,515 | 38,885 |
| Prepaid expenses and other current assets - related party | -117,185 | 731,301 |
| Accounts payable and accrued expenses | 1,288,287 | 427,821 |
| Accounts payable and accrued expenses - related party | -17,755 | 565,273 |
| Accrued interest | 367,817 | 87,994 |
| Lease liabilities | -107,222 | -90,926 |
| Other current liabilities | 961,113 | 388,726 |
| Other liabilities | -235,408 | -276,787 |
| Net cash used in operating activities | -2,455,037 | -1,396,236 |
| Proceeds from loan receivable | 2,366 | 197,117 |
| Purchase of digital assets | 1,000,000 | - |
| Sale of intangible assets | - | 0 |
| Purchase of intangible assets | -96,985 | - |
| Purchase of property and equipment | 12,716 | 35,064 |
| Purchase of intangible assets | - | 97,302 |
| Net cash (used in)/provided by investing activities | -1,010,033 | 64,751 |
| Proceeds from convertible note payable | 9,839,348 | - |
| Payment of note payable | 833,970 | 740,130 |
| Proceeds from note payable | 810,750 | 1,291,001 |
| Payment of related party loan | 151 | 6,549 |
| Proceeds from related party loan | 0 | - |
| Payment of lines of credit | 7,268,023 | 13,849,591 |
| Proceeds from lines of credit | 6,745,349 | 14,053,410 |
| Proceeds from the issuance of common stock | 1,021,934 | - |
| Proceeds from the exercise of warrants | 0 | - |
| Payments of financing fees | 1,698,606 | - |
| Payments of finance lease liability | 2,555 | 4,814 |
| Payment of related party note payable | - | -1,604,348 |
| Payments of financing fees | - | 182,448 |
| Net cash provided by financing activities | 7,192,176 | 2,165,227 |
| Effect of exchange rate changes on cash | 251,051 | -493,344 |
| Net change in cash | 3,978,157 | 340,398 |
| Cash and cash equivalents at beginning of period | 315,105 | - |
| Cash and cash equivalents at end of period | 4,633,660 | - |
Cosmos Health Inc. (COSM)
Cosmos Health Inc. (COSM)